TrialJAMA2012

Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial.

Joshua M Hare et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.